Page 31 - Pipa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India's drug regulator, the Drug Controller General of India (DCGI), plans to review pharmaceutical manufacturing standards in order to ensure the quality, safety, and efficacy of drugs. The DCGI will meet with pharma industry associations to discuss reviewing Good Manufacturing Practices (GMP) for pharma companies. The government aims to upgrade Schedule M, which lays down GMP, to international standards.

How does a ruling against a railway impact how a client collects biometric information?

​​​​​​Cholesteryl Ester Storage Disease (CESD) is a rare autosomal recessive multisystem condition that belongs to the lysosomal storage disorders family.

ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, September 14th. Analysts expect ImmunoPrecise Antibodies to post earnings of ($0.17) per share for the quarter. ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report) last released its earnings results on Monday, July 10th. The […]

IPOH: The Let’s Drum Palo event held in conjunction with the upcoming Visit Perak Year 2024 is expected to draw an audience of more than 2,000.